|
2021
|
Invention
|
Use of aminoacetonitrile compounds for the treatment of infection and disease. The present invent... |
|
2018
|
Invention
|
Anticancer agent comprising aminoacetonitrile compound as active ingredient. The present inventio... |
|
2017
|
Invention
|
Compounds for the treatment of mtor pathway related diseases. The present invention relates to co... |
|
2016
|
Invention
|
Kinase inhibitors for the treatment of cancer.
The present invention relates to kinase inhibitor... |
|
|
Invention
|
Anti-cancer agent comprising aminoacetonitrile compound as active ingredient. 6)alkyl group and t... |
|
|
Invention
|
Anti cancer agent comprising aminoacetonitrile compound as active ingredient. The present inventi... |
|
2014
|
Invention
|
Pharmaceutical combinations for the treatment of cancer. The present invention relates to pharmac... |
|
|
Invention
|
Anticancer agent comprising aminoacetonitrile compound as active ingredient. 6)alkyl group and th... |
|
2013
|
Invention
|
Treatment of diseases involving mucin. The present invention relates to compositions containing o... |
|
|
Invention
|
Kinase inhibitors for the treatment of cancer. The present invention relates to kinase inhibitors... |
|
2012
|
Invention
|
Treatment for cancer. The present invention provides methods for the treatment of tumors, compris... |
|
2005
|
Invention
|
Compositions comprising a taxoid and a benzimidazole carbamate for the treatment of cancer.
|
|
|
Invention
|
Vegf inhibition. The present invention provides methods for inhibiting VEGF production or secreti... |
